Covidien to Sell Specialty Chemicals Business for $280 Million

Reuters -- Healthcare products company Covidien said it had signed a definitive agreement to sell its specialty chemical business to an affiliate of New Mountain Capital LLC for $280 million in cash.

MORE ON THIS TOPIC